Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation.
Fanelli G, Sokolowski M, Wasserman D; European College of Neuropsychopharmacology (ECNP) Network on Suicide Research and Prevention; Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Fabbri C. Fanelli G, et al. Among authors: mendlewicz j. Am J Med Genet B Neuropsychiatr Genet. 2022 Apr;189(3-4):74-85. doi: 10.1002/ajmg.b.32891. Epub 2022 Feb 21. Am J Med Genet B Neuropsychiatr Genet. 2022. PMID: 35191176 Free PMC article.
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. Höfer P, et al. Among authors: mendlewicz j. Int Clin Psychopharmacol. 2016 Jan;31(1):1-7. doi: 10.1097/YIC.0000000000000101. Int Clin Psychopharmacol. 2016. PMID: 26544898
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
Fanelli G, Benedetti F, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Fabbri C. Fanelli G, et al. Among authors: mendlewicz j. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110170. doi: 10.1016/j.pnpbp.2020.110170. Epub 2020 Nov 10. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33181205
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression.
Bartova L, Fugger G, Dold M, Swoboda MMM, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S. Bartova L, et al. Among authors: mendlewicz j. J Psychiatr Res. 2021 Sep;141:167-175. doi: 10.1016/j.jpsychires.2021.06.028. Epub 2021 Jun 16. J Psychiatr Res. 2021. PMID: 34216945 Free article.
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.
Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Maron E, Squassina A, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Baune BT; European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Thematic Working Group; Serretti A, Fabbri C. Fanelli G, et al. Among authors: mendlewicz j. Eur Neuropsychopharmacol. 2022 Feb;55:86-95. doi: 10.1016/j.euroneuro.2021.11.005. Epub 2021 Nov 26. Eur Neuropsychopharmacol. 2022. PMID: 34844152
503 results